Search research articles
Contact Us
Filters
Showing results (61-70 of 174) with videos related to
Page
of 18
Sort By:
Stroke
|
October 1, 1993
Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study
L L Håheim, I Holme, I Hjermann, et al.
Lancet (London, England)
|
December 12, 1981
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men
I Hjermann, K Velve Byre, I Holme, et al.
Scandinavian Journal of Rheumatology
|
January 24, 2009
A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis
L E Dahlberg, I Holme, K Høye, et al.
Scandinavian Journal of Medicine & Science in Sports
|
March 3, 2007
Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study
S A Anderssen, S Carroll, P Urdal, et al.
Journal of Hypertension
|
August 1, 1995
Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study
L L Håheim, I Holme, I Hjermann, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1992
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females
I Jungner, G Walldius, I Holme, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
February 1, 1980
Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study
I Hjermann, P Leren, N Norman, et al.
Blood Pressure. Supplement
|
January 1, 1992
High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study
G Walldius, I Jungner, W Kolar, et al.
American Heart Journal
|
January 1, 1991
Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience
I Holme, P Fauchald, H E Rugstad, et al.
British Medical Journal
|
August 5, 1978
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study
A Helgeland, I Hjermann, P Leren, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 174) with videos related to
Sort By:
Page
of 18
Stroke
|
October 1, 1993
Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study
L L Håheim, I Holme, I Hjermann, et al.
Lancet (London, England)
|
December 12, 1981
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men
I Hjermann, K Velve Byre, I Holme, et al.
Scandinavian Journal of Rheumatology
|
January 24, 2009
A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis
L E Dahlberg, I Holme, K Høye, et al.
Scandinavian Journal of Medicine & Science in Sports
|
March 3, 2007
Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study
S A Anderssen, S Carroll, P Urdal, et al.
Journal of Hypertension
|
August 1, 1995
Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study
L L Håheim, I Holme, I Hjermann, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1992
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females
I Jungner, G Walldius, I Holme, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
February 1, 1980
Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study
I Hjermann, P Leren, N Norman, et al.
Blood Pressure. Supplement
|
January 1, 1992
High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study
G Walldius, I Jungner, W Kolar, et al.
American Heart Journal
|
January 1, 1991
Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience
I Holme, P Fauchald, H E Rugstad, et al.
British Medical Journal
|
August 5, 1978
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study
A Helgeland, I Hjermann, P Leren, et al.
Page
of 18